Filtered By:
Condition: Bleeding
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 448 results found since Jan 2013.
One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting
Int Heart J. 2022;63(3):441-446. doi: 10.1536/ihj.21-705.ABSTRACTOne-stop hybrid coronary revascularization (HCR) is a promising revascularization strategy for treating multivessel coronary artery disease (MVCAD). However, its safety and feasibility remain controversial. Therefore, we introduced our experience with midterm follow-up of HCR in patients with MVCAD and compared it with conventional off-pump coronary artery bypass grafting (CABG).Patients with MVCAD undergoing one-stop HCR at Beijing Chaoyang Hospital between March 2018 and December 2020 were retrospectively enrolled. These patients were matched in a 1:2 ratio...
Source: International Heart Journal - June 1, 2022 Category: Cardiology Authors: Yanyan Li Zhiyong Zhang Jie Gao Chuang Li Kuibao Li Pixiong Su Lefeng Wang Source Type: research
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany
ConclusionLeft main stenting is a safe and effective treatment option for CCS-patients suffering from left main coronary artery disease at reasonable economic cost.Graphic abstractCoronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. All cases with chronic coronary syndrome and left main stenosis treated in 2018 in Germany either with left main stenting or coronary bypass grafting were extracted from a nation-wide database. In-hospital outcomes were compared after logistic regression analysis.
Source: Clinical Research in Cardiology - June 30, 2022 Category: Cardiology Source Type: research
One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting
Int Heart J. 2022;63(3):441-446. doi: 10.1536/ihj.21-705.ABSTRACTOne-stop hybrid coronary revascularization (HCR) is a promising revascularization strategy for treating multivessel coronary artery disease (MVCAD). However, its safety and feasibility remain controversial. Therefore, we introduced our experience with midterm follow-up of HCR in patients with MVCAD and compared it with conventional off-pump coronary artery bypass grafting (CABG).Patients with MVCAD undergoing one-stop HCR at Beijing Chaoyang Hospital between March 2018 and December 2020 were retrospectively enrolled. These patients were matched in a 1:2 ratio...
Source: International Heart Journal - June 1, 2022 Category: Cardiology Authors: Yanyan Li Zhiyong Zhang Jie Gao Chuang Li Kuibao Li Pixiong Su Lefeng Wang Source Type: research
